ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Blue Chip Shares
Buy these top quality ASX 200 shares for your self-managed superannuation fund
Healthcare Shares
ResMed share price outperforms on strong Q4 update
Share Market News
5 things to watch on the ASX 200 on Friday
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Appen, Breville, Credit Corp, and ResMed shares are storming higher today
Share Fallers
Why Fletcher Building, JB Hi-Fi, NIB, and ResMed shares are falling today
Healthcare Shares
Why are ResMed shares tumbling on Monday?
Share Market News
5 Australian shares to buy and hold forever
Healthcare Shares
Do weight loss drugs pose a threat to ResMed shares?
Healthcare Shares
Buy Resmed shares at 'attractive entry level' says top broker
Healthcare Shares
Why the ResMed share price tanked in FY 2024 and what to expect in FY 2025
How to invest
Investing in ASX shares? Why CEO pay DOES matter when misaligned
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
